Skip to content
    DSC Investment logo

    DSC Investment

    Seoul, South KoreaFounded 2012
    dscinvestment.comLinkedIn
    AIBiotech & Life SciencesConsumerHealthcareHardware & SemiconductorsRobotics & AutomationSaaSE-Commerce & Marketplace

    DSC Investment is a Seoul-based venture capital firm founded in 2012, focused on early-stage to growth-stage startups. It is one of the leading VC firms in South Korea, managing over $1 billion in assets across 23 funds, with investments spanning AI, biotech, healthcare, consumer, and deep tech sectors.

    Average disclosed round size is $32.4M (across 61 rounds with reported amounts).

    Find people at DSC Investment on Goldilocks AI

    Portfolio

    68

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    4

    Team

    LY

    Lee Yong-hyun

    Senior Managing Director

    HT

    Han Tae Hoon

    Managing Director

    JK

    Junam Kim

    Managing Director

    KL

    Kyungho Lee

    Managing Director

    DS

    Dongwon Shin

    Partner

    HK

    Hyunjun Kim

    Partner

    JK

    Jongmin Kwon

    Partner

    SK

    Seongmin Kang

    Partner

    DP

    Dongyoung Park

    Investment Analyst

    NK

    Nahyun Kim

    Venture Capitalist & Investment Analyst

    JH

    Jaehyun Hong

    Venture capitalist(Bio)

    JP

    Ji Park

    Investor

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    104 investments
    CompanyRoundAmountDate
    Nex-i logoNex-iIpo—Apr 2026
    BreezeBio logoBreezeBioSeries B—Feb 2026
    BBreeze BioSeries B$60MJan 2026
    Inocras logoInocrasSeries B$31MJan 2026
    BreezeBio logoBreezeBioSeries B$60MJan 2026
    XCENA logoXCENASeries B$135MJan 2026
    GGravityLabsSeries A$17MDec 2025
    Pinetree Therapeutics, Inc. logoPinetree Therapeutics, Inc.Series B$47MOct 2025
    Nex-i logoNex-iSeries B—Aug 2025
    Illimis Therapeutics logoIllimis TherapeuticsSeries B—Jul 2025
    Zordi logoZordiSeries B—May 2025
    MOVIN logoMOVINSeries A—Mar 2025
    Nex-i logoNex-iUnknown—Jan 2025
    MADDE logoMADDESeries A$8.1MJan 2025
    PlayTag logoPlayTagSeries A$2.7MJan 2025
    SSobaGenBridge—Jan 2025
    Illimis Therapeutics logoIllimis TherapeuticsSeries B$42MJan 2025
    Orum Therapeutics logoOrum TherapeuticsUnknown$100MJan 2025
    Pinetree Therapeutics, Inc. logoPinetree Therapeutics, Inc.Series A$17MJul 2024
    Dalpha logoDalphaSeed—Apr 2024
    JJocasta NeuroscienceSeries A$35MJan 2024
    Dimensional Energy logoDimensional EnergySeries A$20MDec 2023
    FFreeWillinSeries B—Jul 2023
    PlayTag logoPlayTagSeries A—May 2023
    Phantom AI logoPhantom AISeries C$36.5MFeb 2023
    Page 1 of 5

    Top Co-Investors

    Korea Investment Partners22 shared
    Atinum Investment15 shared
    IMM Investment13 shared
    STIC Investments, Inc.9 shared
    SV Investment Corporation9 shared
    Woori Venture Partners8 shared
    Industrial Bank of Korea8 shared
    Pontifax8 shared
    AJU IB Investment7 shared
    InterVest6 shared
    Smilegate Investment6 shared
    Korea Development Bank5 shared
    OrbiMed5 shared
    Samsung Venture Investment Corporation5 shared
    Mirae Asset5 shared
    CJ Investment5 shared
    S&S Investment5 shared
    LB Investment4 shared
    SBVA4 shared
    Consensus Business Group4 shared

    Last updated: 20 October 2026